Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

BIZARRE: Seeking alpha - You Need To See This

Northrop Grumman Just Hiked Its Dividend, But Its Stock Has Tanked - Time to Buy NOC?

Northrop Grumman Corp hiked its annual dividend rate by about 7%. But NOC stock is down 26% from its peak and well below its average historical yield. Value investors are also shorting out-of-the-money puts.

Lowe's Delivers Strong Free Cash Flow, But the Stock Fell - Time to Buy LOW?

Lowe's Delivers Strong Free Cash Flow, But the Stock Fell - Time to Buy LOW?

Lowe's Companies delivered strong Q1 free cash flow and is likely to hike its dividend next month. But LOW is down 15% from a recent peak last month and could be worth 35% more at its average historical yield.

Unusual Call Option Activity in CVS Ahead of Its Earnings Shows Investors are Bullish

Unusual Call Option Activity in CVS Ahead of Its Earnings Shows Investors are Bullish

Today, a Barchart report shows unusually heavy call options activity in CVS stock. This highlights bullish moves by some investors ahead of its earnings pre-market opening on May 6.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Airline Stocks Have Been Hard Hit by Iran War, but Citi Is Betting Big on These 2 Names

Citi says Delta and SkyWest are the least sensitive airlines to shocks in oil prices.

Why This Analyst Is Still Pounding the Table on AMD Stock

BNP Paribas is bullish on AMD stock, citing the chipmaker's expanding portfolio of AI products and competitive moat.

Klarna Group plc Shares Surge 8.8% on Chairman's $50 Million Buy Amid Post-IPO Volatility

Klarna Group plc (NYSE: KLAR), the Swedish fintech giant known for its "buy now, pay later" services, saw its shares climb sharply in recent trading as Board Chairman Michael Moritz acquired approximately $50 million worth of stock, signaling confidence in the company's long-term prospects despite ongoing market pressures following its…

International Business Times

Analysts See Domino's Pizza Stock As Too Cheap Ahead of Earnings Next Week

Domino's stock is at a one-year low ahead of full-year earnings due out next week. One play is to sell short out-of-the-money (OTM) put options with a one-month expiry. It has a 2% yield for a 5% lower strike price.

inkl

Read news from The Economist, FT, and more,
with one subscription

Pfizer Reports Strong Earnings Outlook - Unusual Call Options Activity Shows Investors are Bullish

Pfizer Reports Strong Earnings Outlook - Unusual Call Options Activity Shows Investors are Bullish

Pfizer reported strong earnings and earnings guidance. Large, unusual call option activity today, as noted in a Barchart report, indicates investors are bullish.

1 High-Yield Dividend Stock That’s Up 148% Over the Past Year

1 High-Yield Dividend Stock That’s Up 148% Over the Past Year

Millicom International Cellular (TIGO) is up 148% over the past 52 weeks. TIGO maintains a 100% “Buy” technical opinion from Barchart. TIGO's fundamentals are robust with strong revenue and earnings growth estimates. Analyst sentiment is overwhelmingly positive, with multiple “Strong Buy” ratings. Today’s Featured Stock Valued at $11.52 billion, Millicom...

10 Worst-Performing Stocks of 2025

10 Worst-Performing Stocks of 2025

According to StatMuse, Reuters and Seeking Alpha, these are the 10 worst-performing S&P 500 stocks of 2025.

Unusual Call Options Volume in GameStop Corp. Stock - Should Investors Buy GME Stock?

Unusual Call Options Volume in GameStop Corp. Stock - Should Investors Buy GME Stock?

GameStop Corp reported excellent results yesterday for its fiscal Q3 ended Nov. 1. Today, there is a huge, unusual call options trading in GME. GME stock is well off its recent highs. Should investors buy GME stock?

Fannie Freddie IPO Could Make You Rich; Burry Sees Up to 100 % Gain

Fannie Freddie IPO Could Make You Rich; Burry Sees Up to 100 % Gain

Michael Burry predicts Fannie Mae and Freddie Mac shares could double within two years of relisting. Here's what the potential IPO means for ordinary investors eyeing a windfall.

International Business Times UK

This Shipping Stock Has Set 15 New Highs This Month

This Shipping Stock Has Set 15 New Highs This Month

Costamare (CMRE) has strong technical momentum and just set a new 52-week high. Shares have a 100% technical “Buy” opinion from Barchart. CMRE stock is up nearly 30% in just the last month. Analyst sentiment is mixed, but Morningstar sees CMRE as 19% undervalued and Seeking Alpha rates it a...

This Stock Is Up 704% in 2025 But Has No Products to Its Name

This Stock Is Up 704% in 2025 But Has No Products to Its Name

Relmada Therapeutics (RLMD) is a clinical-stage pharma company with no commercialized products and a $141 million market cap. RLMD has shown strong technical momentum, gaining 440% since August. Shares have a 100% “Buy” technical opinion from Barchart. Despite technical strength, RLMD lacks revenue, faces pipeline setbacks, and is rated “Hold”...

Get all your
news in one place.

100's of premium titles.
One news app.

This Canadian Dividend Stock Just Hit New All-Time Highs

Canadian Imperial Bank of Commerce (CM) just hit an all-time high and has strong technical momentum. The stock maintains a 100% “Buy” Barchart opinion. Shares are up 32.01% over the past year and more than 34% in the year to date. Despite some valuation concerns, most analysts rate CM as...

This ‘Strong Buy’ Financial Stock Can Help You Unlock Profits in Peru

Intercorp Financial Services (IFS) is trading at a 5-year high and has strong technical momentum. Shares are up 63% in the past 52 weeks and nearly 50% in the year to date. IFS has a 100% “Buy” opinion from Barchart. Fundamentals remain solid for IFS, with projected revenue and earnings...

Micron Stock Keeps Hitting New Record Highs

Micron Technology (MU) is trading at new all-time highs and has strong technical momentum. MU has a 100% “Buy” opinion from Barchart. The stock is up 125% in the past year and over 180% in the year to date. Analyst sentiment is overwhelmingly bullish, with multiple “Strong Buy” ratings, although...

This Data Center Stock Is Up 1,300% in Just 3 Years

Vertiv (VRT) has exceptional price momentum and is hitting new all-time highs. VRT maintains a 100% “Buy” opinion from Barchart. Shares have surged 75% over the past year and analysts project robust earnings and revenue growth ahead. Vertiv’s growth is fueled by its strategic role in the AI-driven data center...

Get all your
news in one place.

100's of premium titles.
One news app.

4 Tesla Stock Mistakes That Cost Investors Thousands

Tesla's stock is positive for 2025 despite major setbacks it faced earlier this year. Learn the four costly investor mistakes to avoid before jumping in.

This ‘Strong Buy’ Stock Is a Classic – and It Pays a Dividend Too

Ralph Lauren (RL) boasts strong technical momentum and is trading at new all-time highs. Shares have a 100% “Buy” opinion from Barchart and are up 66% over the past year. RL fundamentals are solid, as analysts project revenue and earnings growth. However, there is reason for caution due to Ralph...

This Red-Hot Biopharma Stock Could Fizzle Out Soon

Roivant Sciences (ROIV) shows strong technical momentum and is trading at new all-time highs. Shares are up 52% over the past year and 20% in the last month. ROIV has a 100% “Buy” opinion from Barchart and a Trend Seeker “Buy” signal. Despite the price gains, Roivant lacks consistent revenue...

Alphabet Stock Off Its Peak - Is It Undervalued? It Could Be If FCF Stays Strong

Alphabet stock has declined from its recent peak. But is there any significant upside from here? It's possible, especially if its free cash flow (FCF) remains strong. It could be up to 25% too cheap.

This ‘Darling’ Pharma Stock Is Hitting New Highs

Rigel Pharmaceuticals (RIGL) is showing exceptional momentum, setting new 52-week highs on Aug. 22. Shares are up nearly 243% over the past year. The stock is trading above key moving averages and is supported by several “Strong Buy” analyst ratings. Fundamentals show impressive projected earnings growth this year, but both...

This Penny Stock Has Wall Street's Attention and Is Up Nearly 600%

ImmunoPrecise Antibodies (IPA) shows strong technical momentum, hitting new 52-week highs on Aug. 21. The stock maintains a 100% “Buy” opinion from Barchart. Shares are up an impressive 565% in 2025. Despite bullish analyst sentiment, IPA is volatile and speculative. Today’s Featured Stock Valued at only $121 million, ImmunoPrecise Antibodies...

Pfizer Raises Its Guidance and Analysts Up Their Targets - PFE Stock Looks Cheap

Pfizer stock is incredibly cheap following management's raise of its 2025 adjusted earnings per share guidance. It's at just over 8x this year's estimates and 7.8x next year. That's too cheap. Shorting puts works here.

1 2 3 4

People

Jim Van Meerten

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Delta Air Lines

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

380,531 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play